Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locoregionally Advanced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04446663
What this trial is testing

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
First People's Hospital of Foshan 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02460887
What this trial is testing

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 236
Testing effectiveness (Phase 2)WithdrawnNCT05743270
What this trial is testing

Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLocally Advanced Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Replimune, Inc.
Large-scale testing (Phase 3)UnknownNCT02786641
What this trial is testing

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 235
Large-scale testing (Phase 3)UnknownNCT01854203
What this trial is testing

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 300
Not applicableStudy completedNCT03759730
What this trial is testing

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locoregionally-advanced Oropharyngeal Squamous Cell Carcinoma
University Health Network, Toronto 26
Testing effectiveness (Phase 2)UnknownNCT03932266
What this trial is testing

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital 73
Testing effectiveness (Phase 2)UnknownNCT02871518
What this trial is testing

Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 236
Testing effectiveness (Phase 2)Looking for participantsNCT07457346
What this trial is testing

A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 76
Large-scale testing (Phase 3)Active Not RecruitingNCT04384627
What this trial is testing

Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

Who this might be right for
Nasopharyngeal CarcinomaInduction ChemotherapyRadiotherapy
Sun Yat-sen University 445
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07041788
What this trial is testing

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

Who this might be right for
Cancer
Second Affiliated Hospital of Nanchang University 25
Large-scale testing (Phase 3)UnknownNCT03503136
What this trial is testing

Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 632
Testing effectiveness (Phase 2)Study completedNCT03389295
What this trial is testing

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiayun He, MD 118
Testing effectiveness (Phase 2)Study completedNCT02254278
What this trial is testing

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

Who this might be right for
Stage III Oropharyngeal Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell Carcinoma+2 more
NRG Oncology 316
Large-scale testing (Phase 3)Study completedNCT02297438
What this trial is testing

Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Who this might be right for
Breast Neoplasms
Pfizer 340
Testing effectiveness (Phase 2)UnknownNCT04539600
What this trial is testing

Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer

Who this might be right for
Hypopharyngeal CancerImmunotherapyInduction Chemotherapy
Sun Yat-sen University 23
Testing effectiveness (Phase 2)UnknownNCT01516996
What this trial is testing

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

Who this might be right for
Oropharyngeal CancerHypopharyngeal Cancer
The Second People's Hospital of Sichuan 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT06900218
What this trial is testing

PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 664
Testing effectiveness (Phase 2)Study completedNCT00416455
What this trial is testing

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more
National Cancer Institute (NCI) 384
Large-scale testing (Phase 3)Not Yet RecruitingNCT07373990
What this trial is testing

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 418
Next Page